Evaluating the susceptibility to ceftazidime-avibactam in clinical isolates of Klebsiella pneumoniae and Pseudomonas aeruginosa recovered from an apex medical hospital in north India
Background and Objectives: We assessed the susceptibility of ceftazidime+avibactam (CZA/AVI) in Klebsiella pneumoniae and Pseudomonas aeruginosa isolated from intensive care units of our hospital. Materials and Methods: Clinical samples from Jan 2022 to Dec 2023 at SKIMS Soura, were processed for t...
Saved in:
| Main Authors: | Nargis Bali, Tufail Ahmed, Biswajyoti Borkakoty, Roseleen Bali, Anjum Ara Mir, Zubair Teli, Qounser Nisar, Tantray Faisal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2025-04-01
|
| Series: | Iranian Journal of Microbiology |
| Subjects: | |
| Online Access: | https://ijm.tums.ac.ir/index.php/ijm/article/view/4940 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ceftazidime-avibactam susceptibility against Escherichia coli and Klebsiella pneumoniae
by: Arun Sachu, et al.
Published: (2025-02-01) -
Ertapenem+Meropenem Including Double Carbapenem Therapy (EMDCT) Versus Ceftazidime-Avibactam Therapy In The Therapy Of Carbapenem-Resistant Klebsiella Pneumoniae Infections (CRKPI): A Retrospective Matched Cohort Study
by: Merve Mert Vahabi, et al.
Published: (2024-12-01) -
Ceftazidime-avibactam resistance determination in carbapenem-resistant Klebsiella pneumoniae infections before its use in practice
by: Oya Özlem Eren-Kutsoylu, et al.
Published: (2024-07-01) -
Efficacy of ceftazidime-avibactam with or without polymyxin for carbapenem-resistant Klebsiella pneumoniae infections after initial treatment with polymyxin
by: Jingli Lu, et al.
Published: (2025-01-01) -
IN VITRO ACTIVITY OF CEFTAZIDIME-AVIBACTAM AND COLISTIN AGAINST CARBAPENEM-RESISTANT PSEUDOMONAS AERUGINOSA CLINICAL ISOLATES
by: Tuğrul Hoşbul, et al.
Published: (2022-07-01)